Determinants of colorectal cancer screening in primary care

Journal of Cancer Education

Volumn 23, Issue 4, 2008, Pages 241-247

  Post, Douglas M ^a,c   Katz, Mira L ^a   Tatum, Cathy ^a   Dickinson, Stephanie L ^b   Lemeshow, Stanley ^a   Paskett, Electra D ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b INDIANA UNIVERSITY   (United States)

^c B0902B Cramblett Hall ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER PATIENT; CANCER SCREENING; COLORECTAL CANCER; EDUCATION PROGRAM; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL;

AGED; ATTITUDE TO HEALTH; COLORECTAL NEOPLASMS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION AS TOPIC; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; QUESTIONNAIRES;

EID: 57349195175     PISSN: 08858195     EISSN: None     Source Type: Journal    
DOI: 10.1080/08858190802189089     Document Type: Article

References (30)

1. American Cancer Society: Cancer Facts and Figures, 2006. Atlanta, GA: American Cancer Society; 2006.
2. Surveillance, Epidemiology and End Results (SEER) Program. National Background Incidence Rates for 1999. Bethesda, MD: National Cancer Institute; 2002.
3. US Department of Commerce, Bureau of the Census. 2000 Census of Population, General Population Characteristics, Ohio. Washington, DC: US Bureau of the Census; 2000.
4. Ries LAG, Eisner MP, Kosary CL, et al., eds. SEER Cancer Statistics Review, 1975-2000. Bethesda, MD; National Cancer Institute. Available at: http://seer.cancer.gov/csr/1975_2000/. Accessed August 31, 2006.
5. Towler BP, Irwig L, Glaszious P, et al. Screening for colorectal cancer using the fecal occult blood test, hemoccult. Cochrane Database Syst Rev. 2000;2:CD001216.
6. Mandel JS, Bond JH, Church TR, et al. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst. 1999;91:434-437.
7. Kronborg O, Fenger C, Olsne J, et al. Randomized study of screening for colorectal cancer with fecal-occult blood test. Lancet. 1996;348:1467-1471.
8. Selby JV, Friedman GD, Quesenberry CP, et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653-657.
9. Sonnenberg A, Delco F, Inadomi JM. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med. 2000;133:573-584.
10. Chu KC, Tarone RE, Chow WH, et al. Temporal patterns in colorectal cancer incidence, survival, and mortality from 1950 through 1990. J Natl Cancer Inst. 1994;86:997-1006.
11. Greiner KA, Engleman KK, Hall MA, et al. Barriers to colorectal cancer screening in rural primary care. Prev Med. 2004;38:269-275.
12. Shokar NK, Vernon SW, Weller SC. Cancer and colorectal cancer: knowledge, beliefs, and screening preferences of a diverse patient population. Fam Med. 2005;37:341-347.
13. Cornelius LJ, Smith PL, Simson GM. What factors hinder women of color from obtaining preventive health care? Am J Public Health. 2002;92:535-539.
14. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin. 2006;56:11-25.
15. Paskett ED, D'Agostino R, Tatum C, et al. Colorectal cancer screening practices among low-income women. Clin J Women's Health. 2000;1:3-9.
16. Hosmer D, Lemeshow S. Applied Logistic Regression. 2nd ed. New York: John Wiley & Sons Inc; 2000.
17. SAS System for Windows [computer program]. Version 9.1. SAS/STAT SOFTWARE. Cary, NC: SAS Institute Inc; 2002.
18. Coffield AB, Maciosek MV, McGinnis JM, et al. Priorities among recommended clinical preventive services. Am J Prev Med. 2001;21:1-9.
19. Walsh JM, Terdiman JP. Colorectal cancer screening: Scientific review. JAMA. 2003;289:1288-1296.
20. Pignone M, Saha S, Hoerger T, et al. Cost effectiveness analyses of colorectal cancer screening: a systematic review for the US Preventive Services Task Force. Ann Intern Med. 2002;137:96-104.
21. Subramanian S, Klosterman M, Amonkar MM, et al. Adherence with colorectal cancer screening guidelines: a review. Prev Med. 2004;38:536-550.
22. Behavioral Risk Factor Surveillance System (BRFSS). Atlanta, GA: National Center for Chronic Disease Prevention and Health Promotion. Available at: http://www.cdc.gov/brfss/. Accessed August 31, 2006.
23. Vernon SW, Meissner H, Klabunde C, et al. Measures for ascertaining use of colorectal cancer screening in behavioral, health services, and epidemiological research. Cancer Epidemiol Biomarkers Prev. 2004;13:898-905.
24. Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst. 1997;89:1406-1422.
25. Greene MG, Adelman RD. Physician-older patient communication about cancer. Patient Educ Couns. 2003;50:55-60.
26. Patel P, Forjuoh SN, Avots-Avotins AA, et al. Identifying opportunities for improved colorectal cancer screening in primary care. Prev Med. 2004;39:239-246.
27. Cooper-Patrick L, Gall JJ, Gonzales JJ, et al. Race, gender, and partnership in the patient-physician relationship. JAMA. 1999; 282:583-589.
28. Volk RJ, Cass AR, Spann SJ. A randomized controlled trial of shared decision making for prostate cancer screening. Arch Fam Med. 1999;8:333-340.
29. Hall HI, Van Den Eeden SK, Tolsma DD, et al. Testing for prostate and colorectal cancer: comparison of self-report and medical record audit. Prev Med. 2004;39:27-35.
30. US Department of Health and Human Services. Healthy People 2010: With understanding and Improving Health and Objectives for Improving Health. 2nd ed. Washington, DC: US Government Printing Office; 2000.